Correlation Between Aerovate Therapeutics and WISCONSIN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and WISCONSIN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and WISCONSIN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and WISCONSIN ELEC PWR, you can compare the effects of market volatilities on Aerovate Therapeutics and WISCONSIN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of WISCONSIN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and WISCONSIN.

Diversification Opportunities for Aerovate Therapeutics and WISCONSIN

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aerovate and WISCONSIN is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and WISCONSIN ELEC PWR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WISCONSIN ELEC PWR and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with WISCONSIN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WISCONSIN ELEC PWR has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and WISCONSIN go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and WISCONSIN

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.91 times more return on investment than WISCONSIN. However, Aerovate Therapeutics is 1.1 times less risky than WISCONSIN. It trades about 0.03 of its potential returns per unit of risk. WISCONSIN ELEC PWR is currently generating about -0.11 per unit of risk. If you would invest  256.00  in Aerovate Therapeutics on October 22, 2024 and sell it today you would earn a total of  2.00  from holding Aerovate Therapeutics or generate 0.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy42.11%
ValuesDaily Returns

Aerovate Therapeutics  vs.  WISCONSIN ELEC PWR

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
WISCONSIN ELEC PWR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days WISCONSIN ELEC PWR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for WISCONSIN ELEC PWR investors.

Aerovate Therapeutics and WISCONSIN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and WISCONSIN

The main advantage of trading using opposite Aerovate Therapeutics and WISCONSIN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, WISCONSIN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WISCONSIN will offset losses from the drop in WISCONSIN's long position.
The idea behind Aerovate Therapeutics and WISCONSIN ELEC PWR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine